Ignite Creation Date:
2025-12-24 @ 2:19 PM
Ignite Modification Date:
2026-01-04 @ 1:06 PM
Study NCT ID:
NCT05495295
Status:
RECRUITING
Last Update Posted:
2025-04-08
First Post:
2022-07-27
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-human Trial of PhOx430, a First-in-class Acetylglucosaminyltransferase V Inhibitor, in Advanced Solid Tumours
Sponsor:
Phost'In Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PHOX-CLI_001
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None